Clinical trial for Alzheimer's Disease
Official title Central Auditory Processing Modulation Underlying Anxiety Reduction Using Clinically Designed Improvisatory Music
ClinicalTrials.gov ID: NCT07775625
What this study is testing
- What it's testing
- The study wants to see if the music reduces anxiety and caregiver stress, and if it changes heart rate, blood pressure, and brainwave patterns.
- Who it's for
- People with Alzheimer’s disease who also feel anxious, plus their caregivers.
- What's involved
- Participants will have eight 30‑minute sessions over four weeks, alternating in‑person and online. The music group hears specially designed slow music; the control group listens to calming short stories.
- Time commitment
- The program lasts four weeks, with two 30‑minute sessions each week, plus a few brief tests before and after the sessions.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 55 and older
You may be able to join if
- Clinical diagnosis of Alzheimer's Disease
- Positive Alzheimer's disease biomarkers (blood test, amyloid PET scan or CSF)
- Mini-mental State Exam (MMSE) \>=15
- Rating for Anxiety in Dementia (RAID) score \> 8
You likely can't join if
- Significant hearing impairments
- Major comorbidities Beck Depression Inventory (BDI) scores above \> 10'
The study team makes the final eligibility decision.
Where it is enrolling
- Chicago, Illinois, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 55 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Chicago, Illinois, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.